A Phase I, Open Label Crossover Study to Evaluate the Effect of Etravirine on GSK1265744 Pharmacokinetics in Healthy Adult Subjects.

Trial Profile

A Phase I, Open Label Crossover Study to Evaluate the Effect of Etravirine on GSK1265744 Pharmacokinetics in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2010

At a glance

  • Drugs Cabotegravir (Primary) ; Etravirine
  • Indications HIV infections; HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top